Open AccessHepatocellular Carcinoma with Macrovascular Invasion: Defining the Optimal Treatment Strategy
Author(s) -
Charlotte Costentin,
Cristina R. Ferrone,
Ronald S. Arellano,
Suvranu Ganguli,
Theodore S. Hong,
Andrew X. Zhu
Publication year - 2017
Publication title -
liver cancer
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.916
H-Index - 34
eISSN - 2235-1795
pISSN - 1664-5553
DOI - 10.1159/000481315
Subject(s) - sorafenib , medicine , hepatocellular carcinoma , percutaneous ethanol injection , guideline , selective internal radiation therapy , oncology , carcinoma , percutaneous , gastroenterology , surgery , radiofrequency ablation , pathology , ablation
Tumoral macrovascular invasion (MVI) of hepatic and/or portal vein branches is a common phenomenon in hepatocellular carcinoma (HCC) and is associated with poorer prognosis when compared to HCC without MVI.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom